RGO
Regeneron Pharmaceuticals, Inc. · TRADEGATE:RGO
863.30 EUR35.20 +4.25%
Regeneron Pharmaceuticals, Inc. (TRADEGATE:RGO) last traded at 863.30 EUR, up 4.25% on the day. Over the past year the stock is up 54.82%. Its 52-week range is 508.80 to 869.50. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open825.80
Day range820.00 – 869.50
52-week range508.80 – 869.50
Volume426
Average volume (10 days)212
Market cap (USD)95.51 B
P/E21.59
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)0.0814
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+20.66%1 week
+32.63%1 month
+31.26%3 months
+43.05%6 months
+30.57%Year to date
+54.82%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
- Regeneron Pharma Is Maintained at Buy by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains Regeneron Pharmaceuticals at Buy, raises price target to $1100 from $1030TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.